- Drug Manufacturers - General
- Healthcare
Pfizer Inc.
PFE · US ·
NYSE
28.85
USD
-0.47
(1.63%)
-
-0.46
EPS
-
-63.31
P/E
-
163B
MARKET CAP
-
5.79%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | -0.444 | 3.01 | 2.51 | 2.89 | 3.14 | 2.92 | 53.64% |
| Avg. Estimate | -0.459 | 2.61 | 1.97 | 2.16 | 3.07 | 2.84 | 52.33% |
| Low Estimate | -0.47 | 2.28 | 1.24 | 1.39 | 2.97 | 2.76 | 51.05% |
| No. Of Analysts | 10 | 13 | 11 | 8 | 5 | 6 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 55.5B | 61.4B | 64.7B | 65B | 65.3B | 63.2B | 2.62% |
| Avg. Estimate | 55.2B | 61.1B | 63.2B | 63.8B | 64.1B | 62B | 2.37% |
| Low Estimate | 54.9B | 60.4B | 61.7B | 62.2B | 62.6B | 60.5B | 1.96% |
| No. Of Analysts | 13 | 10 | 14 | 20 | 10 | 9 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | -2.07B | 17.2B | 14.3B | 16.5B | 17.9B | 16.6B | 58.57% |
| Avg. Estimate | -2.59B | 14.9B | 10.6B | 11.5B | 17.5B | 16.2B | 52.55% |
| Low Estimate | -3.11B | 13B | 7.08B | 7.94B | 17B | 15.7B | 47.82% |
| No. Of Analysts | 13 | 10 | 14 | 20 | 10 | 9 |